Proteins were extracted from cell cultures with
RIPA buffer (Sigma-Aldrich, Germany) along with
proteinase and phosphatase inhibitors (Roche, Switzerland). Protein concentration was measured using a BCA kit according to the manufacturer’s protocol (
BCA Protein Assay-Kit, ThermoScientific, Sweden). Protein extracts were then separated by SDS-PAGE using
pre-cast gels (4–20%, Bio-Rad) in
TGS buffer (Bio-Rad, Sweden). The proteins were transferred to
nitrocellulose membranes (Bio-Rad, Sweden) using the
TransBlot Turbo system from Bio-Rad. The membranes were subsequently blocked for 1 h with skim milk at 3% (w/v) in PBS, then washed 3 × 10 min in PBS supplemented with 0.1% (w/v) Tween 20 (PBS-T). Then, blots were incubated with primary antibodies in PBS-T, as mentioned above, overnight. Following this, we incubated the blots with secondary antibodies for 2 h. After the secondary antibody, we washed three times with PBS-T, and then the blots were developed using
ECL Clarity (Bio-Rad) according to the manufacturer’s protocol and imaged using the
ChemiBlot XRS+ system from Bio-Rad.
Boza-Serrano A., Ruiz R., Sanchez-Varo R., García-Revilla J., Yang Y., Jimenez-Ferrer I., Paulus A., Wennström M., Vilalta A., Allendorf D., Davila J.C., Stegmayr J., Jiménez S., Roca-Ceballos M.A., Navarro-Garrido V., Swanberg M., Hsieh C.L., Real L.M., Englund E., Linse S., Leffler H., Nilsson U.J., Brown G.C., Gutierrez A., Vitorica J., Venero J.L, & Deierborg T. (2019). Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease. Acta Neuropathologica, 138(2), 251-273.